Skip to content

Register, Health Services Research, RWE & RWD

BioStats designs, plans, and analyzes registry and health services research projects and prepares Real World Data to deliver robust Real World Evidence for science, regulation, and health economics.
Registry and health services research studies play an increasingly important role in evaluating new therapies and digital health solutions. They make it possible to represent healthcare reality beyond the framework of clinical trials and thus generate additional evidence. BioStats GmbH supports you in the conception, statistical planning, and evaluation of such studies and analyses. Real World Data (RWD) from registries, health insurance records, or other healthcare data sources are prepared to provide robust Real World Evidence (RWE). Challenges such as incomplete data, software errors, or bias are systematically addressed to ensure reliable and transparent results.
Streudiagramm mit roten und blauen Datenpunkten, grünen horizontalen Linien bei 0, 8 und 20 sowie -8 und -20.
Boxplot-Vergleich von zwei Gruppen mit p = 0,003 und einer roten gestrichelten Linie bei Delta = 88,5.
Through this work, a solid foundation is created to demonstrate the effectiveness, safety, and benefits of therapies and digital health solutions in routine care and to answer both scientific questions and regulatory as well as health economic requirements.
Your Contact at BioStats
Contact us for a non-binding conversation with Dr. Alexander Krannich personally.
First and Last Name
Frequently Asked Questions
How does BioStats GmbH support the planning of clinical studies?
What types of studies does BioStats GmbH have experience with?
What statistical methods does BioStats GmbH use?
What expertise does Dr. Alexander Krannich bring?
© 2025 BioStats GmbH. All rights reserved. | Webdesign von Philipp Kufferath